Morgan Stanley
UNCY icon

Morgan Stanley’s Unicycive Therapeutics UNCY Stock Holding History

Morgan Stanley’s Portfolio UNCY Stock Details UNCY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.24M Buy
188,182
+141,598
+304% +$928K ﹤0.01% 5030
2025
Q4 		$269K Buy
46,584
+35,972
+339% +$192K ﹤0.01% 5807
2025
Q3 		$46.3K Buy
10,612
+9,612
+961% +$41.9K ﹤0.01% 6432
2025
Q2 		$4.77K Sell
1,000
-1,227
-55% -$7.59K ﹤0.01% 7045
2025
Q1 		$12.8K Buy
2,227
+1,727
+345% +$10.5K ﹤0.01% 6730
2024
Q4 		$3.97K Buy
+500
New +$2.77K ﹤0.01% 7066
2022
Q1 		– Hold
0
– – – 8124
2021
Q4 		– Hold
0
– – – 8113

Other funds holding UNCY

VC
Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return
Millennium Management
Millennium Management New York $134B AUM 35.51% 1-Year Est. Return
OCA
Octagon Capital Advisors New York $904M AUM 737.04% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $1.6B AUM 121.58% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
GPP
Great Point Partners Greenwich, Connecticut $408M AUM 318.81% 1-Year Est. Return
LGM
Logos Global Management San Francisco, California $1.94B AUM 444.09% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $141B AUM 30.34% 1-Year Est. Return
IHAM
Integral Health Asset Management New York $1.89B AUM 112.84% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return